With plenty of potential information to be communicated among health professionals, pharmacists shouldn't be left out. For many, the pharmacist is the face of healthcare.
Because they are at the point of sale, pharmacies have traditionally been ahead of the technological curve. Their records have been computerized for years, though they've often had to communicate with doctors and patients via phone and fax. E-prescribing and electronic healthcare records (EHRs) promise to change that.
"There's a lot of potential for information to be communicated that way: diagnosis codes, benefits, formulary information, plan information, sales status-all those things can be communicated at various levels," says Harry Hagel, director of the Academy of Managed Care Pharmacy's (AMCP's) Healthcare Information Technology department. "The potential is there. E-prescribing is potentially connected to an electronic healthcare record. That's a lot of information for pharmacists to use when advising patients and resolving problems with medication use."
The benefits are obvious: fewer harmful drug interactions, a reduction in prescription errors, immediate drug regimen adherence information and access to patient medical history. But the hurdles seem just as impressive: determining what information should be shared and by whom, implementing standards and convincing every segment of the industry to adopt them.
"The biggest hurdle is time," says consultant Shelly Spiro, president-elect of the American Society of Consultant Pharmacists. Spiro has served on a number of national and local committees involved in healthcare information technology. "It's very difficult for me because I work day-to-day five years [in the future]," she says. "The things I work on, the average pharmacists won't see for five years. Standards are done first, then adoption. So we're laying groundwork for what will be happening with technology in the future."
John Klimek, senior vice president of Industry IT for the National Council for Prescription Drug Programs (NCPDP), agrees.
Adoption requires time and money. As standards and formats are set, systems need to be modified to use them, pharmacists and clinicians need to be trained, and cultures need to shift.
"Probably the main beef of pharmacists revolves around technology adoption issues and communication issues-having systems that may not communicate seamlessly," says Hagel. "There's the cost of implementing that, the impact on workflow and efficiencies, transaction fees, moving that info along the tech highway-there are fees associated with that. Currently those fees are assigned to pharmacy. Right now, prescribers don't have those fees. Our hope is that as the volume increases, the costs will decrease."
More difficult to quantify, but just as important as costs, is the effort to change mindsets that may be resistant to using new technology. Spiro says some pharmacists and physicians who don't understand what is happening are afraid technology will replace them. Even healthcare professionals who understand technology well may not want to use it because it's new and different.
In the Scope of Virtual Health and the Future of “Website” Manner, Per Ateev Mehrotra
August 10th 2023Briana Contreras, an editor of Managed Healthcare Executive, had the pleasure of catching up with MHE Editorial Advisory Board Member, Ateev Mehrotra, MD, MPH, who is a professor of healthcare policy at Harvard Medical School and an Associate Professor of Medicine and Hospitalist at Beth Israel Deaconess Medical Center.
Listen
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen